Rapport Therapeutics (RAPP) News Today $17.63 +0.83 (+4.94%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$17.80 +0.17 (+0.94%) As of 08/29/2025 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock RAPP Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period T. Rowe Price Investment Management Inc. Trims Position in Rapport Therapeutics, Inc. $RAPPAugust 27, 2025 | marketbeat.comDavid Bredt Sells 8,500 Shares of Rapport Therapeutics, Inc. (NASDAQ:RAPP) StockAugust 20, 2025 | marketbeat.comPositive Outlook for Rapport Therapeutics, Inc. Driven by RAP Technology and Strategic Focus on CNS IndicationsAugust 20, 2025 | tipranks.comRapport Therapeutics, Inc. (NASDAQ:RAPP) Insider Sells $127,500.00 in StockAugust 19, 2025 | insidertrades.comHC Wainwright Issues Negative Forecast for RAPP EarningsAugust 14, 2025 | marketbeat.comRapport Therapeutics (NASDAQ:RAPP) Trading Up 7.3% - Time to Buy?August 13, 2025 | marketbeat.comAnalysts Offer Predictions for RAPP Q2 EarningsAugust 9, 2025 | marketbeat.comRapport Therapeutics Insider Trading Activity | NASDAQ:RAPP | BenzingaAugust 8, 2025 | benzinga.comRapport Therapeutics Short Interest Report - BenzingaAugust 8, 2025 | benzinga.comRapport Therapeutics (NASDAQ:RAPP) Now Covered by Analysts at HC WainwrightAugust 7, 2025 | marketbeat.comRapport Therapeutics Reports Second Quarter 2025 Financials and Provides Business UpdateAugust 7, 2025 | globenewswire.comRapport Therapeutics (RAPP) Expected to Announce Earnings on ThursdayAugust 7, 2025 | marketbeat.comHC Wainwright & Co. Initiates Coverage of Rapport Therapeutics (RAPP) with Buy RecommendationAugust 6, 2025 | msn.comRapport Therapeutics initiated with a Buy at H.C. WainwrightAugust 6, 2025 | msn.comRapport Therapeutics Inc. (RAPP) Stock Price Today - WSJJuly 26, 2025 | wsj.comRapport Therapeutics (NASDAQ:RAPP) Stock Price Up 9.1% - Here's WhyJuly 25, 2025 | marketbeat.comRapport Therapeutics, Inc. (NASDAQ:RAPP) Insider Sells $119,000.00 in StockJuly 16, 2025 | marketbeat.comRapport Therapeutics (NASDAQ:RAPP) Trading Up 5.3% - Time to Buy?July 16, 2025 | marketbeat.comRapport Therapeutics (NASDAQ:RAPP) Shares Down 6.3% - Should You Sell?July 11, 2025 | marketbeat.comRapport Therapeutics (NASDAQ:RAPP) Trading 9.8% Higher - Here's WhyJuly 9, 2025 | marketbeat.comRapport Therapeutics (NASDAQ:RAPP) Receives "Market Outperform" Rating from JMP SecuritiesJuly 8, 2025 | marketbeat.comRapport Therapeutics stock rating reiterated as Buy by TD CowenJuly 2, 2025 | uk.investing.comAnalysts Can't Get Enough of These Little-Known Biopharma Stocks (RAPP)Three relatively unknown biopharma firms receive near-unanimous approval from analysts for their promising drug candidates in development.June 12, 2025 | marketbeat.comStifel reiterates buy rating for Rapport Therapeutics stockJune 5, 2025 | uk.investing.comRapport Therapeutics Hosts Inaugural Investor and Analyst Day to Update on RAP-219 and Clinical PipelineJune 4, 2025 | nasdaq.comRapport Therapeutics (NASDAQ:RAPP) Stock Price Up 16% - Still a Buy?June 4, 2025 | marketbeat.comRapport Therapeutics Hosts Investor and Analyst Day; Provides Corporate UpdatesJune 2, 2025 | globenewswire.comRapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 46th Annual Global Healthcare ConferenceMay 27, 2025 | globenewswire.comRapport Therapeutics (RAPP) to Release Quarterly Earnings on MondayMay 27, 2025 | marketbeat.comRapport Therapeutics to Host 2025 Investor and Analyst DayMay 21, 2025 | globenewswire.comCompanies Like Rapport Therapeutics (NASDAQ:RAPP) Are In A Position To Invest In GrowthMay 16, 2025 | finance.yahoo.comCrestline Management LP Acquires New Stake in Rapport Therapeutics (NASDAQ:RAPP)May 13, 2025 | marketbeat.comRapport Therapeutics Reports Q1 2025 Financial ResultsMay 9, 2025 | tipranks.comOptimistic Buy Rating for Rapport Therapeutics Driven by Promising RAP-219 DevelopmentsMay 8, 2025 | tipranks.comPromising Clinical Developments and Strategic Initiatives Drive Buy Rating for Rapport Therapeutics, Inc.May 8, 2025 | tipranks.comRapport Therapeutics Reports First Quarter 2025 Financials and Provides Business UpdateMay 8, 2025 | globenewswire.comInductive Bio Raises $25M Series A to Transform Small Molecule Drug Discovery with Industry-Wide AI PlatformMay 7, 2025 | finance.yahoo.comRapport Therapeutics (NASDAQ:RAPP) Stock Position Boosted by Price T Rowe Associates Inc. MDMay 4, 2025 | marketbeat.comMise à disposition du rapport financier annuel 2024April 30, 2025 | globenewswire.comRapport Therapeutics (NASDAQ:RAPP) Shares Sold by T. Rowe Price Investment Management Inc.April 29, 2025 | marketbeat.comRapport Therapeutics (NASDAQ:RAPP) Short Interest UpdateApril 22, 2025 | marketbeat.comRapport Therapeutics to Participate in Upcoming Investor ConferencesApril 22, 2025 | globenewswire.comTrv Gp V LLC Invests $126.58 Million in Rapport Therapeutics (NASDAQ:RAPP)April 22, 2025 | marketbeat.comTrv Gp Vi LLC Invests $17.19 Million in Rapport Therapeutics (NASDAQ:RAPP)April 22, 2025 | marketbeat.comMeloni and Trump: An Oval Office Meeting With Rapport and BanterApril 18, 2025 | nytimes.com48,452 Shares in Rapport Therapeutics (NASDAQ:RAPP) Acquired by Norges BankApril 14, 2025 | marketbeat.comJMP Securities Initiates Coverage on Rapport Therapeutics (NASDAQ:RAPP)April 10, 2025 | marketbeat.comCitizens Jmp Begins Coverage on Rapport Therapeutics (NASDAQ:RAPP)April 10, 2025 | marketbeat.comRapport Therapeutics initiated with an Outperform at Citizens JMPApril 9, 2025 | markets.businessinsider.comBuy Rating for Rapport Therapeutics: Promising Precision Therapeutics for CNS DisordersApril 9, 2025 | tipranks.com Get Rapport Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RAPP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RAPP Media Mentions By Week RAPP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RAPP News Sentiment▼1.191.09▲Average Medical News Sentiment RAPP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RAPP Articles This Week▼22▲RAPP Articles Average Week Get the Latest News and Ratings for RAPP and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Rapport Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies RXRX News Today OCUL News Today IRON News Today CGON News Today BLTE News Today MESO News Today ADPT News Today SRPT News Today ANIP News Today ARQT News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RAPP) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rapport Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rapport Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RAPP Stock Alerts